Iv. Turko et al., BINDING OF CGMP TO BOTH ALLOSTERIC SITES OF CGMP-BINDING CGMP-SPECIFIC PHOSPHODIESTERASE (PDE5) IS REQUIRED FOR ITS PHOSPHORYLATION, Biochemical journal, 329, 1998, pp. 505-510
cGMP-binding phosphodiesterases contain two homologous allosteric cGMP
-binding sites (sites (a) under bar and (b) under bar) that are arrang
ed in tandem; they constitute a superfamily of mammalian cyclic nucleo
tide receptors distinct from the cyclic nucleotide-dependent protein k
inases/cation channels family. The functional role of each of these tw
o sites in the phosphodiesterases is not known. The cGMP-binding sites
of one of these phosphodiesterases, the cGMP-binding cGMP-specific ph
osphodiesterase (cGB-PDE, PDES), have been analysed by using site-dire
cted mutagenesis. Mutations that affect cGMP binding to either one or
both allosteric sites do not influence cGMP hydrolysis in the catalyti
c site under the conditions used. However, compared with wildtype enzy
me, the D289A, D478A and D289A/D478A mutants, which are defective in c
GMP binding to either site (a) under bar or site (b) under bar, or bot
h allosteric sites, require much higher cGMP concentrations for the al
losteric stimulation of phosphorylation by the catalytic subunit of cA
MP-dependent protein kinase. The cGMP effect is on the cGB-PDE rather
than on the catalytic subunit of the protein kinase because the latter
enzyme does not require cGMP for activity. The D289N mutant, which ha
s higher binding affinity for cGMP than does the wild-type enzyme, is
phosphorylated at lower concentrations of cGMP than is the wildtype en
zyme. It is concluded that cGMP binding to the allosteric sites of cGB
-PDE does not directly affect catalysis, but binding to both of these
sites regulates phosphorylation of this enzyme.